Related Experiment Video
Updated: Jul 10, 2026
07:54
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
SERS nanoparticles: a new optical detection modality for cancer diagnosis
Michael Y Sha1, Hongxia Xu, Sharron G Penn
1Oxonica Inc, 665 Clyde Avenue, Suite A, Mountain View, CA 94043, USA.
Nanomedicine (London, England)
|November 3, 2007
Summary
Surface-enhanced Raman scattering (SERS) nanoparticles offer sensitive, multiplexed detection for oncology. This study highlights their application in novel nucleic acid assays for cancer diagnostics.
Area of Science:
- Nanotechnology
- Optical Spectroscopy
- Biomedical Diagnostics
Background:
- Surface-enhanced Raman scattering (SERS) provides superior sensitivity and multiplexing compared to traditional assays.
- SERS detection is robust and feasible in complex biological samples like blood.
- SERS-active nanoparticles represent a novel platform for advanced detection methods.
Purpose of the Study:
- To explore the application of SERS-active nanoparticles in oncology.
- To demonstrate the utility of SERS nanoparticles for detecting cancer biomarkers such as PSA, BRCA1, and Her-2.
- To present a novel homogeneous, single-tube, rapid nucleic acid detection assay.
Main Methods:
- Utilized SERS-active nanoparticles for biomolecular detection.
- Developed and tested assays for specific cancer biomarkers (PSA, BRCA1, Her-2).
- Implemented a novel homogeneous, single-tube, rapid nucleic acid detection assay.
Main Results:
- SERS-active nanoparticles show promise for sensitive and multiplexed detection of cancer biomarkers.
- Demonstrated successful nucleic acid detection using SERS nanoparticles.
- Validated a novel homogeneous, single-tube assay for rapid nucleic acid analysis.
Conclusions:
- SERS-active nanoparticles offer significant advantages for oncological detection.
- The developed SERS-based nucleic acid assay provides a rapid and efficient tool for the oncology community.
- This technology has the potential to advance cancer diagnostics and patient care.
